![Michael DeGeorge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael DeGeorge
Keine laufenden Positionen mehr
Profil
Michael DeGeorge served as Director-Medical Affairs at Ameritox LLC from 2011 to 2015 and as Vice President-Medical Affairs at Collegium Pharmaceutical, Inc. from 2015 to 2022.
He received his undergraduate degree from St. John's University in 2000 and his doctorate from the University of Florida in 2004.
Ehemalige bekannte Positionen von Michael DeGeorge
Unternehmen | Position | Ende |
---|---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ameritox LLC
![]() Ameritox LLC Medical/Nursing ServicesHealth Services Ameritox Ltd. engages in the development of pain medication monitoring solutions for pain management. The firm offers laboratory services and practice management tools to help clinicians coordinate and optimize the care of chronic pain patients. Its pain medication monitoring solutions include the Rx Guardian process, a urine drug testing to help clinicians assess whether patients are taking their medications correctly. The company was founded by Ronald C. Backer and Joel A. McEndree in 1996 and is headquartered in Columbia, MD. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2015 |
Ausbildung von Michael DeGeorge
University of Florida | Doctorate Degree |
St. John's University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Ameritox LLC
![]() Ameritox LLC Medical/Nursing ServicesHealth Services Ameritox Ltd. engages in the development of pain medication monitoring solutions for pain management. The firm offers laboratory services and practice management tools to help clinicians coordinate and optimize the care of chronic pain patients. Its pain medication monitoring solutions include the Rx Guardian process, a urine drug testing to help clinicians assess whether patients are taking their medications correctly. The company was founded by Ronald C. Backer and Joel A. McEndree in 1996 and is headquartered in Columbia, MD. | Health Services |